SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000475
Filing Date
2024-09-13
Accepted
2024-09-13 17:22:10
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 17317
  Complete submission text file 0001610717-24-000475.txt   18859
Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
Aurora Daljit Singh (Reporting) CIK: 0001793971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41802 | Film No.: 241298684

Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Issuer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)